How to Get GLP-1 in Yonkers, NY for Weight Loss

The short answer

If you live in Yonkers and are considering GLP-1 medication for weight loss, you have more than one way to get a prescription. Most people start with their primary care provider, see a practice that specializes in weight management or obesity medicine, or use a telehealth program whose providers are licensed in New York. In every case, a licensed provider reviews your health history and decides whether a GLP-1 medication fits, and not everyone receives a prescription. An estimated 29.3% of Yonkers adults have obesity, according to CDC PLACES 2023 data, below both the New York (29.5%) and national (33.1%) rates. As of October 2026, New York Medicaid does not cover GLP-1 medications prescribed for weight loss. Read on for how each option works, the Medicaid facts, and what to check before you pick a provider.

Obesity and metabolic health in Yonkers

The CDC estimates that 29.3% of Yonkers adults have obesity (95% confidence interval 25.9% to 32.6%), out of an adult population of about 166,003. That is lower than the statewide New York rate of 29.5% (2024) and lower than the national rate of 33.1% (2024).

City figures: CDC PLACES: Local Data for Better Health, Place Data, 2025 release, 2023 estimates. State and national figures: CDC BRFSS. Full sources and methodology are listed at the bottom of this page.

The full health picture in Yonkers

Obesity rarely travels alone. The same CDC dataset estimates several related measures for Yonkers adults, each of which is part of what a provider weighs when deciding whether a GLP-1 medication is appropriate:

Yonkers vs other New York cities

City-level obesity estimates vary meaningfully across New York. Compare Yonkers with nearby-ranked New York cities:

• Irondequoit obesity and GLP-1 access: 31.1% adult obesity
• Tonawanda Town obesity and GLP-1 access: 31.0% adult obesity
• Levittown obesity and GLP-1 access: 28.1% adult obesity
• New Rochelle obesity and GLP-1 access: 26.6% adult obesity

Or compare every New York city we track, plus Medicaid coverage rules and how New York compares with other states, on the statewide New York page.

Does New York Medicaid cover GLP-1 medications for weight loss?

Medicaid rules are set at the state level, so what matters for Yonkers residents is the New York program. As of October 2026, New York Medicaid does not cover GLP-1 medications prescribed for weight loss. New York Medicaid excludes drugs used for weight loss under state regulation 18 NYCRR 505.3(g)(3). The weight-management semaglutide product is approvable only with established cardiovascular disease and the weight-management tirzepatide product only for obstructive sleep apnea, each requiring a BMI of 40 or higher and limited to two treatment attempts per lifetime. Coverage rules change frequently, vary by plan, and almost always require prior authorization when weight-management GLP-1s are covered at all. Confirm your current benefits directly with New York Medicaid or your plan administrator before making any decisions.

Nationally, obesity-drug coverage in Medicaid remains limited. As of October 2026, our review of the 51 Medicaid programs (50 states and DC) found 8 that cover at least one GLP-1 medication for weight management, usually with prior authorization, 3 that cover them only under narrow conditions, and 8 that ended that coverage in 2025 or 2026. Coverage for type 2 diabetes is more common and is separate from weight-management coverage.

GLP-1 telehealth in Yonkers: no clinic visit required

If you do not have coverage, do not meet your plan’s criteria, or would rather not go through prior authorization, you will most likely pay cash. In Yonkers that usually means one of two routes:

• In-person care. A primary care provider, an obesity medicine specialist, or a weight management clinic in Yonkers. You get face-to-face visits and local lab work, and the prescription is filled at a retail or compounding pharmacy.
• Telehealth. An online program whose providers are licensed in New York. Visits happen by questionnaire, messaging, or video, and medication is usually shipped to your address.

With telehealth there is no office to drive to and no need to fit appointments around work. In-person care can make it easier to manage other health conditions alongside a GLP-1 medication. Either way, you do not need a diabetes diagnosis to be evaluated for weight management, and a licensed provider decides whether a prescription is appropriate. Before you choose, check each option on the same points:

• Licensing in New York. The prescriber must hold a license that covers New York. You can confirm a license on the New York licensing board’s website.
• The pharmacy. Which pharmacy fills the prescription, whether it is a retail or compounding pharmacy, and whether it is licensed to ship to New York.
• The medication and form. Brand-name or compounded, semaglutide or tirzepatide, injection or tablet.
• Total cost, including dose increases. Many programs charge more as the dose goes up, so ask what you would pay at each dose, not only in the first month.
• What the price includes. Provider visits and follow-ups, lab work, shipping, and any program fee. Some programs bundle these; others bill them separately.
• How the first visit works. An online questionnaire, messaging, or a live video visit. State telehealth rules and each program’s own policy both affect this.
• Cancellation and refund terms. How to pause or stop, and whether you are charged if a provider decides a prescription is not appropriate.

For more on reading GLP-1 prices, see what GLP-1 treatment costs, or start with the GLP-1 weight loss guide.

Compounded semaglutide and tirzepatide in Yonkers

Some telehealth programs and clinics that serve Yonkers residents prescribe compounded semaglutide or compounded tirzepatide, usually at a lower advertised price than brand-name products. Compounded medications are prepared by state-licensed compounding pharmacies and require a prescription from a licensed provider. If a program offers one, ask which pharmacy prepares it and confirm that the pharmacy is licensed to dispense in New York.

Compounded medications are not FDA-approved and may differ from brand-name products in formulation, purity, and potency, so a provider should review whether one is appropriate for you before anything is prescribed. These guides cover the specifics:

• How to get compounded semaglutide online
• How to get compounded tirzepatide online
• Compounded GLP-1 without insurance, including how cash-pay pricing works
• What compounded semaglutide costs

Who qualifies for GLP-1 weight management in Yonkers

You do not need a diabetes diagnosis to be considered for GLP-1 weight management. A licensed provider generally evaluates candidates with a body mass index (BMI) of 30 or higher, or 27 or higher when paired with a weight-related health condition such as high blood pressure, elevated cholesterol, or prediabetes. The provider reviews your full health history, current medications, and goals before deciding whether treatment is appropriate, so the decision is always individual and never automatic.

On age, each program sets its own limits, and most telehealth weight-management programs serve adults 18 and older. New York rules on consent to medical care can also affect the minimum age, so confirm the requirement with any program you are considering. A licensed provider makes the final prescribing decision.

A large share of people seeking GLP-1 weight management in Yonkers are women between roughly 35 and 50 who are navigating weight changes tied to perimenopause, when shifting hormones can make weight harder to manage even when nothing else has changed. If that describes you, the appetite and metabolic effects of GLP-1 medications are one option worth discussing with a provider. You can read more about whether GLP-1 medications are appropriate if you are not diabetic and how GLP-1 medications work.

How to get GLP-1 in Yonkers

For someone in Yonkers, the steps usually look like this:

1. Check your coverage. If you have New York Medicaid or private insurance, find out whether it covers GLP-1 medications for weight management and what prior authorization requires.
2. Choose a route: an in-person provider in Yonkers, or a telehealth program whose providers are licensed in New York.
3. Compare two or three options on licensing, pharmacy, total cost, and what the price includes, using the checklist above.
4. At the program or practice you choose, a licensed provider reviews your health history, current medications, and goals and decides whether a GLP-1 medication is appropriate. Not everyone receives a prescription.
5. If a prescription is written, a pharmacy fills it. Telehealth programs usually ship the medication to your address.

For coverage rules and how New York compares with other states, see the statewide New York data.

Data sources and methodology

• City health estimates: CDC PLACES: Local Data for Better Health, Place Data, 2025 release, 2023 estimates for Yonkers, New York (Census place 3684000). PLACES figures are model-based small-area estimates: the CDC combines BRFSS survey responses with Census population data to produce city-level figures. They are the CDC’s official local estimates, but they are estimates rather than direct city surveys, which is why each figure is shown with its 95% confidence interval.
• State and national benchmarks: CDC Nutrition, Physical Activity, and Obesity, Behavioral Risk Factor Surveillance System. New York adult obesity 29.5% (2024); national 33.1% (2024). Based on self-reported height and weight.
• Medicaid coverage: Transformation Health review of each state’s Medicaid preferred drug list, prior-authorization criteria, and provider notices, as of October 2026. New York-specific status verified against the New York Medicaid preferred drug list and prior-authorization criteria, the state’s primary source. State Medicaid coverage of GLP-1 medications for weight loss changes frequently and is summarized here for general information only. Always confirm current benefits directly with New York Medicaid or your plan.
• Data current as of: 2023 CDC PLACES release. Page last updated: October 17, 2026.